家长小组干预管理自闭症谱系障碍幼儿挑战性受限重复行为的临床与成本效果试验:随机对照试验研究方案
本研究为多中心随机对照试验,比较管理重复行为(MRB)家长小组干预与自闭症心理教育家长小组(LAA)对3岁至9岁11个月自闭症儿童的临床与成本效果。计划纳入250名家长(干预组125名,心理教育组125名,每中心约83名),主要结局为24周时受限重复行为改善的儿童比例,采用广义估计方程分析,并按意向性治疗原则进行。
要点
- MRB家长小组干预旨在帮助家长识别、理解并应对儿童挑战性受限重复行为。
- 主要结局为24周时受限重复行为改善的儿童比例,采用GEE比较两组。
- 经济评价从NHS成本和家庭社区服务可及性两个视角进行。
核心结论
- 该试验旨在评估MRB家长小组干预对比LAA心理教育小组在改善自闭症幼儿挑战性受限重复行为方面的临床与成本效果。
研究设计与样本
- 多中心随机对照试验,计划纳入250名家长(MRB组125名,LAA组125名,每中心约83名),儿童年龄3岁至9岁11个月且诊断为自闭症。
- 所有分析按意向性治疗原则进行,主要结局采用广义估计方程(GEE)比较两组24周时受限重复行为改善的儿童比例,并考虑家长小组聚类。
关键数值与推荐
- 主要结局为24周时受限重复行为改善的儿童比例,采用GEE比较MRB组与LAA组。
- 经济评价从NHS成本和家庭获取当地社区服务两个视角进行,结果表示为24周时CGI-I量表达到至少目标改善的每增加一名儿童的增量成本。
临床怎么用
- 若干预有效,该家长小组干预有望改善自闭症儿童及其家庭福祉、减少家长压力、增强社区参与和学习潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Restricted and repetitive behaviours vary greatly across the autism spectrum, and although not all are problematic some can cause distress and interfere with learning and social opportunities. We have, alongside parents, developed a parent group based intervention for families of young children with autism, which aims to offer support to parents and carers; helping them to recognise, understand and learn how to respond to their child's challenging restricted repetitive behaviours. METHODS: The study is a clinical and cost-effectiveness, multi-site randomised controlled trial of the Managing Repetitive Behaviours (MRB) parent group intervention versus a psychoeducation parent group Learning About Autism (LAA) (n = 250; 125 intervention/125 psychoeducation; ~ 83/site) for parents of young children aged 3-9 years 11 months with a diagnosis of autism. All analyses will be done under intention-to-treat principle. The primary outcome at 24 weeks will use generalised estimating equation (GEE) to compare proportion of children with improved RRB between the MRB group and the LAA group. The GEE model will account for the clustering of children by parent groups using exchangeable working correlation. All secondary outcomes will be analysed in a similar way using appropriate distribution and link function. The economic evaluation will be conducted from the perspective of both NHS costs and family access to local community services. A 'within trial' cost-effectiveness analysis with results reported as the incremental cost per additional child achieving at least the target improvement in CGI-I scale at 24 weeks. DISCUSSION: This is an efficacy trial to investigate the clinical and cost-effectiveness of a parent group based intervention designed to help parents understand and manage their child's challenging RRB. If found to be effective, this intervention has the potential to improve the well-being of children and their families, reduce parental stress, greatly enhance community participation and potential for learning, and improve longer-term outcomes. TRIAL REGISTRATION: Trial ID: ISRCTN15550611 Date registered: 07/08/2018. Sponsor and Monitor: Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust R&D Manager Lyndsey Dixon, Address: St Nicholas Hospital, Jubliee Road, Gosforth, Newcastle upon Tyne NE3 3XT, lyndsey.dixon@cntw.nhs.uk , Tel: 0191 246 7222.
引用
- Grahame V, Dixon L, Fletcher-Watson S, et al. A clinical and cost-effectiveness trial of a parent group intervention to manage challenging restricted and repetitive behaviours in young children with autism spectrum disorder: study protocol for a randomised controlled trial. Trials. 2021. PMID: 33794962. doi:10.1186/s13063-021-05175-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。